Abstract. Glucose-stimulated insulin release from rat pancreas is known to be blunted by aging. In the present study, we examined the effect of aging on insulin release induced by various secretagogues using the isolated perfused pancreas of female rats. Insulin release from the perfused pancreas in response to 16.7mM glucose in 8-month-old rats (older rats) was much less than that in 2-month-old rats (young rats). The first phase of insulin release after glucose stimulation was attenuated in older rats. The addition of 0.1mM 3-isobutyl-1-methylxanthine (IBMX) protentiated glucose-inducedinsulin secretion in both groups of rats. However, the second phase of insulin secretion in older rats was lower than that in younger rats. The phorbol ester 12-0-tetradecanoyl phorbol ester
in the right panel of Fig. 4 . The total amount of insulin secreted during the second phase was slightly but significantly greater in older rats than that in young rats.
The insulin content without the perfusion experiment, which was designated as time zero (T0), was significantly greater in older rats than in younger rats (Table 2) . After the isolated pancreas was perfused with glucose, in either the presence or absence of TPA, the insulin content was significantly increased in young rats. Tolbutamide was the most potent secretagogue in increasing insulin content in young rats. In contrast, perfusion with glucose alone did not change insulin content in older rats, while TPA and tolbutamide significantly enhanced insulin content in the pancreas perfused with glucose in old rats. The insulin secretion ratio in the pancreas from older rats was significantly lower than that in young rats when the pancreas was perfused with 16.7mM glucose. The addition of IBMX and TPA increased the insulin secretion ratio both in young and older rats. However, it was consistently lower in older rats than in young rats. 
